Burning Rock Biotech Ltd - American Depository Shares ("ADSs") of the Issuer, each ADS representing ten Class A Ordinary Shares, par value $0.0002 per share. (BNR)

CUSIP: 12233L206

Q2 2025 13F Holders as of 30 Jun 2025

Security type / class
Equity / American Depository Shares ("ADSs") of the Issuer, each ADS representing ten Class A Ordinary Shares, par value $0.0002 per share.
Total 13F shares
1,445,762
Total 13F value
$4,571,204
Holder snapshot 6 signals
Share change
-758,884
SEC-reported price per share
$3.16
Number of holders
17
Value change
-$2,836,549
Number of buys
3
Number of sells
7
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
8,815,531

Security key

12233L206

Report period

Q2 2025

Institutions

17

Top holders

10

BNR full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2025 Previous quarter: Q1 2025 Burning Rock Biotech Ltd SEC filings Burning Rock Biotech Ltd company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of BNR - Burning Rock Biotech Ltd - American Depository Shares ("ADSs") of the Issuer, each ADS representing ten Class A Ordinary Shares, par value $0.0002 per share. (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Kynam Capital Management, LP
Disclosed value leader
Kynam Capital Management, LP
Comparable rows
15/15
Latest evidence
31 Mar 2025
13F Lead comparable stake: 11% Showing 1-6 of 15 holder rows.

Quick read

Kynam Capital Management, LP leads the comparable SEC ownership view at 11%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Kynam Capital Management, LP's linked filing trail.
Comparable ownership Top 5
Kynam Capital Management, LP 11%
MASSACHUSETTS FINANCIAL SERVICES ... 4.2%
FIL Ltd 3.2%
CRCM LP 2.6%
MILLENNIUM MANAGEMENT LLC 1.6%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Kynam Capital Management, LP
13F
Company
13F
11%
$4,379,688
994,883 shares
 — 31 Mar 2025
MASSACHUSETTS FINANCIAL SERVICES CO /MA/
13F
Company
13F
4.2%
$1,660,458
368,999 shares
 — 31 Mar 2025
FIL Ltd
13F
Company
13F
3.2%
$1,179,772
280,898 shares
 — 31 Mar 2025
CRCM LP
13F
Company
13F
2.6%
$1,018,283
226,290 shares
 — 31 Mar 2025
MILLENNIUM MANAGEMENT LLC
13F
Company
13F
1.6%
$591,003
140,715 shares
 — 31 Mar 2025
Sumitomo Mitsui Trust Group, Inc.
13F
Company
13F
0.5%
$197,672
43,928 shares
 — 31 Mar 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
17
Shares
1,445,762
Rows available
17
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 holders
18
Q2 2025 holders
17
Holder diff
-1
Investor Q1 2025 Shares Q2 2025 Shares Share Diff Share Chg % Q1 2025 value Q2 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .